PMDA drug package insert
ベオビュ硝子体内注射用キット120mg/mL
PMDA Prescription drug · ノバルティスファーマ株式会社 · package insert Nov 20, 2025
Key facts
| Brand names | ベオビュ硝子体内注射用キット120mg/mL |
|---|---|
| Nonproprietary names | ブロルシズマブ（遺伝子組換え） |
| Companies | 製造販売（輸入）／ノバルティスファーマ株式会社 |
| Product type | Prescription drug |
| Therapeutic category | 眼科用VEGF阻害剤 （ヒト化抗VEGFモノクローナル抗体一本鎖Fv断片）VEGF：VASCULAR ENDOTHELIAL GROWTH FACTOR（血管内皮増殖因子） |
| Therapeutic category codes | 871319 |
| YJ codes | 1319406G1024 |
| Approval numbers | 30200AMX00429000 |
| Package insert edition | 第8版 |
| Package insert date | Nov 20, 2025 |
| PMDA document key | 300242_1319406G1024_1 |
| PMDA company code | 300242 |
At a glance
- 1–9 Package insert revisions
- 10–99 Related PMDA documents
- None Safety communications
- Yes PMDA review report published
- Yes Risk management plan (RMP)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About PMDA approved drugs and package inserts (Japan)
Japan's PMDA publishes the package insert (添付文書) of every prescription drug, OTC drug and regenerative medical product, with brand and nonproprietary names, YJ codes and approval numbers. Names appear in Japanese as published.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan, package insert database · Source date: